How to assess cardiac amyloidosis with CMR (cardiac magnetic resonance imaging)

CMR is a great tool when you suspect amyloidosis in your patients. It's also a great alternative to biopsy and much more sensitive and specific than an echo. In this short video, cardiac imaging expert Andrew Houghton will teach you everything you need to know about this rare but important disease.
This video was taken from our CME-accredited CMR Essentials course. If you want to learn more about CMR ⬇️
📘 Discover the First Chapter Free: bit.ly/Cardiac-MRI-Essentials
🌟 Unlock More with Your Trial Access: bit.ly/3RYsXwp

[@ebos514]

I think you are pretty wrong in the dark blood pool reasoning. It has nothing to do with binding of the gadolinium to amyloid. The reason is diffuse delayed enhancement of the wall, retaining off the gadolinium because of the enlarged extracellular matrix. Therefore the technician will pick the wrong(too short) inversion time, also cancelling out the signal from the blood, which normally has a shorter IR time compared to normal myocardium.